茴香酰化纤溶酶原链激酶激活剂复合物及其他溶栓药物在动物和人体中的药代动力学特性。 - Suppr

Suppr

超能文献

Pharmacokinetic properties of anisoylated plasminogen streptokinase activator complex and other thrombolytic agents in animals and in humans.

作者信息

Nunn B, Esmail A, Fears R, Ferres H, Standring R

机构信息

Beecham Pharmaceuticals Research Division, Great Burgh, Epsom.

出版信息

Drugs. 1987;33 Suppl 3:88-92. doi: 10.2165/00003495-198700333-00013.

DOI:10.2165/00003495-198700333-00013

PMID:3315618

Abstract

摘要

相似文献

Pharmacokinetic properties of anisoylated plasminogen streptokinase activator complex and other thrombolytic agents in animals and in humans.

Drugs. 1987;33 Suppl 3:88-92. doi: 10.2165/00003495-198700333-00013.

Development of anisoylated plasminogen-streptokinase activator complex from the acyl enzyme concept.

Semin Thromb Hemost. 1989 Apr;15(2):129-39. doi: 10.1055/s-2007-1002695.

Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Drugs. 1987;33 Suppl 3:33-50. doi: 10.2165/00003495-198700333-00005.

Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.

Pharmacotherapy. 1990;10(2):115-26.

Anistreplase for acute coronary thrombosis.

Med Lett Drugs Ther. 1990 Feb 23;32(812):15-6.

Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.

Drugs. 1987;33 Suppl 3:247-52. doi: 10.2165/00003495-198700333-00046.

Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.

Drugs. 1987;33 Suppl 3:183-5. doi: 10.2165/00003495-198700333-00031.

Evaluation of the efficacy and safety of anisoylated plasminogen streptokinase activator complex in early myocardial infarction. Preliminary results.

Drugs. 1987;33 Suppl 3:186-8. doi: 10.2165/00003495-198700333-00032.

[Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].

Arch Mal Coeur Vaiss. 1990 Feb;83 Spec No 1:31-6.

[Effects of anistreplase on coronary patency in acute myocardial infarction].

Arch Mal Coeur Vaiss. 1990 Feb;83 Spec No 1:25-9.

引用本文的文献

Recent insights on biochemical and molecular basis for developing antihaemostatic agents: A review.

Indian J Clin Biochem. 2004 Jan;19(1):122-8. doi: 10.1007/BF02872406.

Pharmacokinetic optimisation of the treatment of embolic disorders.

Clin Pharmacokinet. 1995 Jan;28(1):67-92. doi: 10.2165/00003088-199528010-00006.

Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Drugs. 1987;33 Suppl 3:33-50. doi: 10.2165/00003495-198700333-00005.

A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.

Br J Clin Pharmacol. 1991 Feb;31(2):143-7. doi: 10.1111/j.1365-2125.1991.tb05502.x.

本文引用的文献

THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.

J Lab Clin Med. 1965 May;65:713-31.

Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits.

Thromb Haemost. 1981 Oct;46(3):658-61.

Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.

Circulation. 1985 Jan;71(1):110-6. doi: 10.1161/01.cir.71.1.110.

High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: description of effects in the circulation.

Am J Cardiol. 1986 Jun 1;57(15):1220-6. doi: 10.1016/0002-9149(86)90192-x.

[Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct].

Klin Wochenschr. 1986 Aug 1;64(15):682-7. doi: 10.1007/BF01712052.

Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.

Int J Cardiol. 1986 Apr;11(1):53-61. doi: 10.1016/0167-5273(86)90199-3.

Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.

Ann Intern Med. 1986 Mar;104(3):345-8. doi: 10.7326/0003-4819-104-3-345.

Thrombolytic therapy in the eighties.

Blood. 1986 Jun;67(6):1529-41.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验